cas 601-88-7|| where to buy 1,3-Dichloro-2-nitrobenzene

Produktname:1,3-Dichloro-2-nitrobenzene

IUPAC Name:1,3-dichloro-2-nitrobenzene

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM253934-100g	in stock	ƈǸ
CM253934-500g	in stock	ƚƴƴ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 601-88-7 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:601-88-7; Molekulare Formel:C6H3Cl2NO2; Schmelzpunkt:-; SMILES-Code:[O-][N+](=O)C1=C(Cl)C=CC=C1Cl; Dichte:

: Katalognummer:CM253934; Molekulargewicht:192; Siedepunkt:; Mdl-Nr.:MFCD00456795; Lagerung:Store at room temperature.

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: Brilaroxazine; Reviva announced an enrollment update to the ongoing 1-year open-label extension (OLE) study evaluating the long-term safety and tolerability of Brilaroxazine in patients with schizophrenia.
Brilaroxazine is a discovered new chemical entity with potent affinity and selectivity against key serotonin and dopamine receptors implicated in schizophrenia and its comorbid symptoms.